Amalgamated Bank Increases Position in The Procter & Gamble Company (NYSE:PG)

Amalgamated Bank increased its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 1.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 492,107 shares of the company’s stock after buying an additional 8,836 shares during the quarter. Procter & Gamble accounts for about 0.7% of Amalgamated Bank’s portfolio, making the stock its 19th largest position. Amalgamated Bank’s holdings in Procter & Gamble were worth $85,233,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Itau Unibanco Holding S.A. purchased a new position in Procter & Gamble during the 2nd quarter worth $28,000. Fairway Wealth LLC purchased a new stake in Procter & Gamble during the 2nd quarter valued at about $29,000. Ruedi Wealth Management Inc. grew its stake in Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after purchasing an additional 77 shares during the last quarter. POM Investment Strategies LLC purchased a new stake in Procter & Gamble during the 2nd quarter valued at about $34,000. Finally, Quest Partners LLC purchased a new stake in Procter & Gamble during the 2nd quarter valued at about $36,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Stock Performance

NYSE:PG opened at $165.08 on Tuesday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The company has a fifty day moving average of $171.52 and a two-hundred day moving average of $168.13. The stock has a market capitalization of $388.77 billion, a PE ratio of 28.46, a P/E/G ratio of 3.57 and a beta of 0.42. The Procter & Gamble Company has a fifty-two week low of $142.50 and a fifty-two week high of $177.94.

Procter & Gamble (NYSE:PGGet Free Report) last issued its earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. The business had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company’s quarterly revenue was down .6% compared to the same quarter last year. During the same period in the prior year, the business earned $1.83 earnings per share. As a group, research analysts forecast that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.44%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is 69.48%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. Morgan Stanley boosted their price target on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Barclays downgraded Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a research note on Monday, September 30th. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Dbs Bank downgraded Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. Finally, Stifel Nicolaus lifted their target price on shares of Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a report on Monday, July 22nd. Nine investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and an average target price of $177.00.

Check Out Our Latest Analysis on Procter & Gamble

Insider Activity

In related news, CEO Jon R. Moeller sold 72,174 shares of the company’s stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $171.01, for a total value of $12,342,475.74. Following the completion of the sale, the chief executive officer now owns 263,158 shares of the company’s stock, valued at approximately $45,002,649.58. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the transaction, the insider now owns 11,566 shares of the company’s stock, valued at $1,954,538.34. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Jon R. Moeller sold 72,174 shares of the stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $171.01, for a total transaction of $12,342,475.74. Following the transaction, the chief executive officer now directly owns 263,158 shares of the company’s stock, valued at approximately $45,002,649.58. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 385,771 shares of company stock worth $65,610,975 over the last three months. Insiders own 0.18% of the company’s stock.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.